The Protected use of TILDREN hasn't been evaluated in horses below 4 years of age. The outcome of bisphosphonates about the skeleton of developing horses has not been examined; even so, bisphosphonates inhibit osteoclast activity which impacts bone turnover and could influence bone development. Bisphosphonates could potentially cause signs of co